z-logo
open-access-imgOpen Access
A comprehensive overview of mitochondrial DNA 4977-bp deletion in cancer studies
Author(s) -
Abdul Aziz Mohamed Yusoff,
Wan Salihah Wan Abdullah,
Siti Zulaikha Nashwa Mohd Khair,
Siti Muslihah Abd Radzak
Publication year - 2019
Publication title -
oncology reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.637
H-Index - 21
eISSN - 1970-5565
pISSN - 1970-5557
DOI - 10.4081/oncol.2019.409
Subject(s) - mitochondrial dna , carcinogenesis , mitochondrion , mitochondrial biogenesis , genome , heteroplasmy , cancer , genetics , biogenesis , biology , computational biology , medicine , gene
Mitochondria are cellular machines essential for energy production. The biogenesis of mitochondria is a highly complex and it depends on the coordination of the nuclear and mitochondrial genome. Mitochondrial DNA (mtDNA) mutations and deletions are suspected to be associated with carcinogenesis. The most described mtDNA deletion in various human cancers is called the 4977-bp common deletion (mDNA) and it has been explored since two decades. In spite of that, its implication in carcinogenesis still unknown and its predictive and prognostic impact remains controversial. This review article provides an overview of some of the cellular and molecular mechanisms underlying mDNA formation and a detailed summary about mDNA reported in various types of cancers. The current knowledges of mDNA as a prognostic and predictive marker are also discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom